Comparable findings were also obtained in ALS patients, where frontal cortical APE1 levels, as well as activity were significantly reduced [195], and in some cases missense mutations within the APE gene were identified [196]. This evidence concerns the gene APEX1 and amyotrophic lateral sclerosis.